In analyzing the import forecast of insulin to Japan, the values show an upward trend from 2024 to 2028, increasing annually from $4.1096 million in 2024 to $4.702 million in 2028. Comparing year-on-year percentage variations, there is a consistent growth: approximately 3.7% from 2024 to 2025, 3.5% from 2025 to 2026, 3.3% from 2026 to 2027, and 3.2% from 2027 to 2028. The calculated CAGR over the five-year period, from 2023 to 2028, stands at 3.4% per year.
Future trends to watch for include advancements in diabetes care technology, changes in international trade policies, and the evolving healthcare needs of Japan's aging population, which may influence the insulin import dynamics.
